Elicio Therapeutics

ELTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$38.063 M

$1.41 -9.94%

Close of 6 Nov 2026

As of 6 Nov 2026, Elicio Therapeutics (ELTX) has a market capitalization of $38.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$39.6M

Loss-making

Shares outstanding

28,307,225

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#350Hyperion DefiHYPD$39.8M
#351Dogwood TherapeuticsDWTX$39.8M
#352Elicio TherapeuticsELTX$38.1M
#353Grace TherapeuticsGRCE$37.7M
#354Impact BiomedicalIBO$37.6M

What if Elicio Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,042,290

Per share 741,843× higher

Bitcoin $1.53T

$56,396.50

Per share 40,140× higher

Apple $5.02T

$185,144.44

Per share 131,775× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Elicio Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.